Summary: Study reveals how certain genetic mutations can shorten the timing of the circadian clock, making some people extreme “morning larks” because their internal clock operates on a 20-hour cycle, as opposed to a 24-hour cycle.
Source: UC Santa Cruz
A new study of molecular interactions central to the functioning of biological clocks explains how certain mutations can shorten clock timing, making some people extreme “morning larks” because their internal clocks operate on a 20-hour cycle instead of being synchronized with the 24-hour cycle of day and night.
The study, published February 11 in eLife, shows that the same molecular switch mechanism affected by these mutations is at work in animals ranging from fruit flies to people.
“Many people with sleep phase disorders have changes in their clock proteins,” said Carrie Partch, associate professor of chemistry and biochemistry at UC Santa Cruz and a corresponding author of the paper. “Generally, mutations that make the clock run shorter have a morning lark effect, and those that make the clock run longer have a pronounced night owl effect.”
In the new study, researchers focused on mutations in an enzyme called casein kinase 1 (CK1), which regulates a core clock protein called PERIOD (or PER). Clock-altering mutations in CK1 had been known for years, but it was unclear how they changed the timing of the clock.
CK1 and other kinase enzymes carry out a reaction called phosphorylation, adding a phosphate to another protein. It turns out that CK1 can phosphorylate either of two sites on the PER protein. Modifying one site stabilizes PER, while the other modification triggers its degradation. Partch and her colleagues showed how mutations in either CK1 or PER itself can alter the balance, favoring degradation over stabilization.
PER proteins are part of a complex feedback loop in which changes in their abundance set the timing of circadian rhythms, so mutations that increase the rate of PER degradation throw off the clock.
“What we discovered is this neat molecular switch that controls the abundance of the PER proteins. When it’s working right, it generates a beautiful 24-hour oscillation,” Partch said.
Partch’s lab performed structural and biochemical analyses of the CK1 and PER proteins that suggested how the switch works. To confirm that the interactions observed in the test tube matched the behavior of the proteins in living cells, they worked with researchers at the Duke-NUS Medical School in Singapore. Other collaborators at UC San Diego performed simulations of the molecular dynamics of the switch showing how the CK1 protein switches between two conformations, and how mutations cause it favor one conformation over another.
The switch involves a section of the CK1 protein called the activation loop. One conformation of this loop favors binding of CK1 to the “degron” region of PER, where phosphorylation leads to the protein’s degradation. The clock-changing mutations in CK1 cause it to favor this degron-binding conformation.
The other conformation favors binding to a site on the PER protein known as the FASP region, because mutations in this region lead to an inherited sleep disorder called Familial Advanced Sleep Phase Syndrome. The stabilization of PER can be disrupted by either the FASP mutations, which interfere with the binding of CK1 to this region, or by the mutations in CK1 that favor the alternate conformation of the activation loop.
The new findings also suggest why binding of CK1 to the FASP region stabilizes PER. With phosphorylation of the FASP region, that region then acts to bind and inhibit CK1, preventing it from adopting the other conformation and phosphorylating the degron region.
“It binds and locks the kinase down, so it’s like a pause button that prevents the PERIOD protein from being degraded too soon,” Partch said. “This stabilizing region builds a delay into the clock to make it align with Earth’s 24-hour day.”
Partch noted that it is important to understand how these clock proteins regulate our circadian rhythms, because those rhythms affect not only the sleep cycle but almost every aspect of our physiology. Understanding these molecular mechanisms may enable scientists to develop therapies for intervening in the clock to alleviate disruptions, whether they are caused by inherited conditions or by shift work or jet lag.
“There might be ways to mitigate some of those effects,” she said.
CK1 is also interesting because it seems to be the most ancient component of biological clocks. The whole feedback loop involving CK1, PERIOD, and other core clock proteins is found in all animals from insects to humans. CK1, however, is also found in every other organism with eukaryotic (nonbacterial) cells, including single-celled green algae in which it has been implicated in circadian rhythms.
“Our results provide a mechanistic foundation to understand the essentially universal role of CK1 as a regulator of eukaryotic circadian clocks,” Partch said.
In addition to Partch, the authors of the paper include co-first authors Jonathan Philpott at UCSC, Rajesh Narasimamurthy at Duke-NUS Medical School, and Clarisse Ricci at UC San Diego, as well as coauthors Alfred Freeberg, Sabrina Hunt, Lauren Yee, Rebecca Pelofsky, and Sarvind Tripathi at UCSC, and corresponding author David Virshup at Duke-NUS Medical School.
Funding: This work was funded by the U.S. National Institutes of Health and the National Medical Research Council of Singapore.
About this neuroscience research article
Source: UC Santa Cruz Media Contacts: Tim Stephens – UC Santa Cruz Image Source: The image is credited to Clarisse Ricci/UCSD.
Casein kinase 1 dynamics underlie substrate selectivity and the PER2 circadian phosphoswitch
Post-translational control of PERIOD stability by Casein Kinase 1δ and ε (CK1) plays a key regulatory role in metazoan circadian rhythms. Despite the deep evolutionary conservation of CK1 in eukaryotes, little is known about its regulation and the factors that influence substrate selectivity on functionally antagonistic sites in PERIOD that directly control circadian period. Here we describe a molecular switch involving a highly conserved anion binding site in CK1. This switch controls conformation of the kinase activation loop and determines which sites on mammalian PER2 are preferentially phosphorylated, thereby directly regulating PER2 stability. Integrated experimental and computational studies shed light on the allosteric linkage between two anion binding sites that dynamically regulate kinase activity. We show that period-altering kinase mutations from humans to Drosophila differentially modulate this activation loop switch to elicit predictable changes in PER2 stability, providing a foundation to understand and further manipulate CK1 regulation of circadian rhythms.